Robert Iannone, M.D., M.S.C.E

2021

In 2021, Robert Iannone, M.D., M.S.C.E earned a total compensation of $4M as Executive Vice President, Global Head of Research and Development at Jazz Pharmaceuticals, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$380,000
Salary$591,923
Stock Awards$3,018,091
Other$11,322
Total$4,001,336

MSCE received $3M in stock awards, accounting for 75% of the total pay in 2021.

MSCE also received $380K in non-equity incentive plan, $591.9K in salary and $11.3K in other compensation.

Rankings

In 2021, Robert Iannone, M.D., M.S.C.E's compensation ranked 3,345th out of 12,415 executives tracked by ExecPay. In other words, MSCE earned more than 73.1% of executives.

ClassificationRankingPercentile
All
3,345
out of 12,415
73rd
Division
Manufacturing
1,360
out of 5,505
75th
Major group
Chemicals And Allied Products
554
out of 2,375
77th
Industry group
Drugs
493
out of 2,096
77th
Industry
Pharmaceutical Preparations
341
out of 1,546
78th

Pay ratio

Robert Iannone, M.D., M.S.C.E's Pay$4,001,336
Median Employee's Pay$212,134
Pay Ratio

19

to 1

In 2021, the annual total compensation of Robert Iannone, M.D., M.S.C.E was $4,001,336.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.

The ratio of Robert Iannone, M.D., M.S.C.E's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on June 10, 2022.

MSCE's colleagues

We found four more compensation records of executives who worked with Robert Iannone, M.D., M.S.C.E at Jazz Pharmaceuticals in 2021.

2021

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2021

Daniel Swisher

Jazz Pharmaceuticals

President

2021

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2021

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

News

You may also like